Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -0.34%390.2M | -15.32%788.61M | -19.02%391.51M | 4.70%931.28M | 15.59%483.44M | 20.65%889.45M | 29.44%418.23M | 22.68%737.22M | --323.1M | 38.85%600.91M |
| Operating income | -0.34%390.2M | -15.32%788.61M | -19.02%391.51M | 4.70%931.28M | 15.59%483.44M | 20.65%889.45M | 29.44%418.23M | 22.68%737.22M | 323.1M | 38.85%600.91M |
| Cost of sales | 1.99%-317.52M | 8.28%-720.8M | 18.33%-323.98M | -13.69%-785.9M | -26.73%-396.7M | -25.42%-691.25M | -26.90%-313.02M | -25.21%-551.15M | ---246.67M | -32.71%-440.18M |
| Operating expenses | 1.99%-317.52M | 8.28%-720.8M | 18.33%-323.98M | -13.69%-785.9M | -26.73%-396.7M | -25.42%-691.25M | -26.90%-313.02M | -25.21%-551.15M | -246.67M | -32.71%-440.18M |
| Gross profit | 7.63%72.68M | -53.36%67.81M | -22.14%67.53M | -26.65%145.38M | -17.55%86.74M | 6.52%198.21M | 37.65%105.21M | 15.77%186.07M | 76.43M | 58.98%160.73M |
| Selling expenses | 7.58%-11.03M | -10.65%-26.3M | -24.12%-11.94M | -11.13%-23.77M | -2.75%-9.62M | -55.11%-21.39M | -96.83%-9.36M | -45.90%-13.79M | ---4.76M | -37.45%-9.45M |
| Administrative expenses | 12.02%-39.14M | 20.88%-89.49M | 22.95%-44.48M | -10.67%-113.1M | -27.28%-57.73M | -6.20%-102.19M | 5.70%-45.36M | -47.11%-96.23M | ---48.1M | -7.67%-65.41M |
| Impairment and provision | -673.29%-25.1M | -72.66%-312.56M | 36.22%-3.25M | -294.26%-181.02M | 74.31%-5.09M | -275.18%-45.91M | -368.58%-19.81M | -193.20%-12.24M | ---4.23M | -195.80%-4.17M |
| -Goodwill impairment | ---- | ---140.22M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | -673.29%-25.1M | 4.80%-172.33M | 36.22%-3.25M | -294.26%-181.02M | 74.31%-5.09M | -275.18%-45.91M | -368.58%-19.81M | -193.20%-12.24M | ---4.23M | -195.80%-4.17M |
| Special items of operating profit | 55.36%3.07M | -206.27%-3.15M | 120.02%1.98M | -68.85%2.97M | 354.67%899K | -9.03%9.52M | -115.14%-353K | -72.32%10.46M | --2.33M | -40.34%37.8M |
| Operating profit | -95.08%484K | -114.51%-363.69M | -35.25%9.84M | -543.46%-169.54M | -49.88%15.2M | -48.53%38.23M | 39.89%30.33M | -37.84%74.28M | 21.68M | 18.09%119.5M |
| Financing income | -33.97%521K | -19.29%1.2M | -11.65%789K | -32.76%1.49M | -40.94%893K | 5.63%2.21M | 816.36%1.51M | 1,511.54%2.1M | --165K | 154.90%130K |
| Financing cost | -30.00%-39K | 36.75%-74K | 50.82%-30K | -53.95%-117K | -144.00%-61K | -58.33%-76K | -177.78%-25K | 99.86%-48K | ---9K | 35.96%-34.37M |
| Share of profits of associates | -91.01%170K | -418.90%-928K | 1.34%1.89M | -62.01%291K | 255.24%1.87M | 231.60%766K | --525K | --231K | ---- | ---- |
| Share of profit from joint venture company | -24.31%545K | -32.47%416K | 39.53%720K | 1,107.84%616K | --516K | --51K | ---- | ---- | ---- | ---- |
| Earning before tax | -87.28%1.68M | -117.06%-363.07M | -28.25%13.21M | -506.12%-167.27M | -43.06%18.41M | -46.20%41.19M | 48.10%32.34M | -10.20%76.56M | 21.84M | 79.20%85.26M |
| Tax | 81.25%-714K | 36.53%43.7M | 15.55%-3.81M | 368.94%32M | 46.74%-4.51M | 34.68%-11.9M | -14.47%-8.46M | 7.51%-18.22M | ---7.39M | -48.45%-19.7M |
| After-tax profit from continuing operations | -89.72%967K | -136.12%-319.37M | -32.36%9.4M | -561.87%-135.26M | -41.76%13.9M | -49.80%29.29M | 65.32%23.87M | -11.01%58.34M | 14.44M | 91.10%65.56M |
| Earning after tax | -89.72%967K | -136.12%-319.37M | -32.36%9.4M | -561.87%-135.26M | -41.76%13.9M | -49.80%29.29M | 65.32%23.87M | -11.01%58.34M | 14.44M | 91.10%65.56M |
| Minority profit | 57.86%-734K | -1.46%-1.04M | -490.58%-1.74M | -218.82%-1.03M | -66.24%446K | 7,772.73%866K | --1.32M | --11K | ---- | ---- |
| Profit attributable to shareholders | -84.74%1.7M | -137.15%-318.33M | -17.18%11.15M | -572.32%-134.23M | -40.33%13.46M | -51.28%28.42M | 56.17%22.55M | -11.03%58.33M | 14.44M | 92.80%65.56M |
| Basic earnings per share | -84.88%0.0044 | -138.11%-0.831 | -3.00%0.0291 | -571.62%-0.349 | -50.00%0.03 | -58.19%0.074 | 20.00%0.06 | -25.63%0.177 | 0.05 | 0.238 |
| Diluted earnings per share | -84.88%0.0044 | -138.11%-0.831 | -3.00%0.0291 | -571.62%-0.349 | -50.00%0.03 | -58.19%0.074 | 20.00%0.06 | -25.63%0.177 | 0.05 | 0.238 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.